ELV240816P470000
- 2.00
- +0.25+14.29%
Elevance Health Newsroom
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)
Kamala Harris' Potential Impact on Health Care Stocks
With President Joe Biden earlier Sunday saying he will end his campaign for re-election and endorsing Vice President Kamala Harris, the focus now turns on her positions on issues.
Elevance Health Is Maintained at Buy by TD Cowen
Elevance Health Is Maintained at Buy by TD
Express News | TD Cowen Maintains Buy on Elevance Health, Lowers Price Target to $589
Baird Adjusts Price Target on Elevance Health to $625 From $649
Elevance Health (ELV) has an average rating of outperform and price targets ranging from $550 to $665, according to analysts by Capital IQ.Price: 503.00, Change: -1.72, Percent Change: -0.34
Elevance Health Second Quarter 2024 Earnings: EPS Beats Expectations
Express News | Elevance Health Inc : TD Cowen Cuts Target Price to $589 From $624
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by
Elevance Health's Medicaid Margin Outlook Has BofA Taking Sideline -- Market Talk
1359 ET - Managed care provider Elevance Health said Medicaid membership attrition was only partially offset by premium rate increases to reflect medical cost trends, when it reported operating
A Closer Look at Elevance Health's Options Market Dynamics
Financial giants have made a conspicuous bearish move on Elevance Health. Our analysis of options history for Elevance Health (NYSE:ELV) revealed 8 unusual trades.Delving into the details, we found 12
Elevance Health, Other Health Benefits Firms Face 'Cloudy' Future, BofA Says
Elevance Health (ELV) reported better-than-expected Q2 results and reiterated its 2024 financial forecast, overcoming a double-digit decline in memberships for Medicaid plans, although that did
Express News | Elevance Health Shares Are Trading Lower After B of A Securities Downgraded the Stock From Buy to Neutral and Cut Its Price Target From $646 to $530
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Elevance Health Price Target Raised to $585.00/Share From $575.00 by RBC Capital
Elevance Health Price Target Raised to $585.00/Share From $575.00 by RBC
Elevance Health Is Maintained at Outperform by RBC Capital
Elevance Health Is Maintained at Outperform by RBC
Express News | Elevance Health Inc : BofA Global Research Cuts to Neutral From Buy; Cuts Price Objective to $530 From $646
A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $530 to $643
On Jul 18, major Wall Street analysts update their ratings for $Elevance Health(ELV.US)$, with price targets ranging from $530 to $643.Morgan Stanley analyst Erin Wright maintains with a buy rating,
Elevance Health Cut to Neutral From Buy by B of A Securities
Elevance Health Cut to Neutral From Buy by B of A
Elevance Health (ELV) Receives a Buy From Truist Financial
Express News | Elevance Health : Deutsche Bank Raises Target Price to $565 From $558